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Heparan sulphate (HS) 3-O-sulphotransferase transfers sulphate
to the 3-OH position of the glucosamine residue of HS to form
3-O-sulphated HS. The HS modified by 3-O-sulphotransferase
isoform 3 binds to HSV-1 (herpes simplex virus type 1) gD (envel-
ope glycoprotein D), and the resultant 3-O-sulphated HS serves
as an entry receptor for HSV-1. In the present paper, we report
the isolation and characterization of a novel HS 3-O-sulpho-
transferase isoform, designated HS 3-O-sulphotransferase iso-
form 6 (3-OST-6). Mouse 3-OST-6 gene was identified in the EST
(expressed sequence tag) database and cloned into pcDNA3.1/
Myc-His vector. A CHO (Chinese-hamster ovary) cell line that
stably expresses 3-OST-6 (3OST6/CHO cells) was prepared. The
disaccharide analysis of the HS isolated from 3OST6/CHO cells
revealed that 3-OST-6 exhibits HS 3-O-sulphotransferase activity.
Furthermore, 3OST6/CHO cells were susceptible to infection by
HSV-1, but not by other alphaherpesviruses examined, suggesting
that 3-OST-6 produces a specific entry receptor for HSV-1.
Our results indicate that a new member of 3-OST family gen-
erates an entry receptor for HSV-1. The findings add to the
growing body of evidence that HSV-1 entry is mediated by 3-O-
sulphated HS generated by multiple members of 3-O-sulpho-
transferases.
Key words: heparan sulphate, heparin, herpes simplex virus
(HSV), sulphotransferase, viral entry.
INTRODUCTION
Heparan sulphate (HS) is a highly sulphated and unbranched
polysaccharide. The disaccharide repeats of HS are GlcA (glu-
curonic acid) or IdoA (iduronic acid) and glucosamine with var-
ious sulphations (structures shown in Figure 1). HSs are widely
present on the surface of mammalian cells and in the extracellular
matrix. HSs are involved in many biological processes, including
blood coagulation, viral infections, embryonic development,
wound healing and tumour growth suppression [1–6]. The bio-
synthesis of HS occurs in the Golgi apparatus. After the poly-
saccharide backbone is synthesized, it is subjected to various
modifications. These modifications include N-deacetylation and
N-sulphation of glucosamine, C5-epimerization of GlcA to form
IdoA residues, 2-O-sulphation of GlcA or IdoA residues, as well
as 6-O-sulphation and 3-O-sulphation of glucosamine residues.
The enzymes that carry out the modifications have been cloned,
including HS C5-epimerase, N-deacetylase/N-sulphotransferase,
2-O-sulphotransferase, 6-O-sulphotransferase and 3-O-sulpho-
transferase [7].
HS 3-O-sulphotransferase (3-OST) transfers sulphate from
PAPS (adenosine 3′-phosphate 5′-phosphosulphate) to the 3-OH
position of glucosamine residue to form the 3-O-sulphated HS
as illustrated in Figure 1. Six different isoforms of 3-OST have
been identified (3-OST-1, -2, -3A, -3B, -4 and -5). Among them,
3-OST-3A and 3-OST-3B have nearly identical amino acid
sequences in the sulphotransferase domain and generate the same
3-O-sulphated disaccharides [8,9]. These isoforms share greater
than 60% identity in the sulphotransferase domain and exhibit
distinct tissue expression patterns [10,11]. In addition, the iso-
forms recognize the unique saccharide sequences around the
modification site [10,12]. The substrate specificity of 3-OST-1,
3-OST-3 and 3-OST-5 has been studied extensively, and is pre-
sented in Figure 1. The resultant 3-O-sulphated HS generated by
different isoforms display distinct biological functions. For in-
stance, the HS modified by 3-OST-1 and by 3-OST-5 contain
anticoagulant activity, whereas the HS modified by 3-OST-3 and
3-OST-5 serve as entry receptors for HSV-1 (herpes simplex virus
type 1) [9,13–15].
HSV-1 belongs to the alphaherpesviruses subfamily of the
herpesvirus family. Infections with HSV-1 are highly prevalent in
humans and cause localized mucocutaneous lesions and encepha-
litis in rare cases [16,16a]. It has been known that the cell-
surface HS plays an important role in assisting HSV-1 attachment
to host cells [17], as well as in inducing viral entry into the target
cells [6,18]. The attachment process primarily involves the inter-
action between HS and the virion envelope gC (glycoprotein C)
and/or gB [19]. Specific sulphated saccharide structures probably
contribute to the binding of HS and gC [20]. Following the
attachment, HSV-1 enters the target cells by interacting with
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Figure 1 Substrate specificity of 3-OSTs and the structure of HS disaccharide repeating unit
3-OST-1 transfers sulphate to the 3-OH position of a glucosamine N-sulphate (GlcNS +− 6S) unit that is linked to a GlcA unit to form the 3-O-sulphated HS containing GlcA-GlcNS3S +− 6S, which is
an anticoagulant HS. 3-OST-3 transfers sulphate to the 3-OH position of an N-unsubstituted glucosamine unit (GlcNH2 +− 6S) that is linked to an IdoA2S unit to form the 3-O-sulphated HS containing
IdoA2S-GlcNH23S +− 6S, which is an entry receptor for HSV-1. Both 3-OST-3A and 3-OST-3B have nearly identical amino acid sequences in the sulphotransferase domain, and sulphate identical
disaccharides. For clarity, 3-OST-3 represents both 3-OST-3A and 3-OST-3B, unless specified. 3-OST-5 transfers sulphate to the 3-OH position of a modified glucosamine unit (GlcNH2 +− 6S or
GlcNS +− 6S) that is linked to various GlcA or IdoA/IdoA2S units. The HS modified by 3-OST-5 displays anticoagulant activity and serves as entry receptor for HSV-1. The numbers indicate the
positions of saccharide unit. The 3-O-sulphation by 3-OSTs is shaded and indicated in bold. R represents a proton (-H) or a sulphate group (-SO3).
specific cell-surface entry receptors to establish the infection.
Three families of HSV-1 entry receptors are present on the target
cell surface and bind to viral envelope gD [21]. HVEM (her-
pesvirus entry mediator) and nectin-1 represent two families of
those receptors, which belong to the TNFR (tumour necrosis
factor receptor) family and the immunoglobulin superfamily
respectively [22,23]. The 3-O-sulphated HS, which is generated
by 3-OST-3 and 3-OST-5, represents the third family of HSV-1
entry receptor [9,14]. This receptor is unique as it is a poly-
saccharide and contains a specific saccharide structure. Our
research attention has been focused on the identification of the
role of 3-O-sulphated HS in assisting the entry of HSV-1 and
the enzymes involved in the biosynthesis of this subtype of HS. We
have identified the structure of a gD-binding octasaccharide from
3-OST-3-modified HS [24]. Supporting the role of 3-O-sulphated
HS in assisting HSV-1 entry, two putative 3-O-sulphated HS
binding pockets on gD were observed in the co-crystal of gD
and HVEM [25]. One of the putative 3-O-sulphated HS binding
sites is located at the N-terminal of gD. The virus carrying gD
mutations in this N-terminal domain is unable to infect the cells
expressing 3-OST-3, confirming the location of a 3-O-sulphated-
HS-binding site as predicted by the crystal structure [26].
In the present paper, we report that a novel isoform of 3-OST,
designated 3-OST-6, generates a HSV-1 entry receptor. The HS
isolated from stably transfected 3OST6/CHO (Chinese-hamster
ovary cell line that stably expresses 3-OST-6) cells contains
the characteristic gD-binding disaccharides, IdoA2S-AnMan3S
(where IdoA2S is L-IdoA 2-O-sulphate and AnMan3S is
2,5-anhydromannitol 3-O-sulphate) and IdoA2S-AnMan3S6S
(where AnMan3S6S is 2,5-anhydromannitol 3,6-O-disulphate).
Accordingly, we also found that 3OST6/CHO cells are susceptible
to HSV-1 infection. The newly identified enzyme provides an
additional tool for understanding the relationship between the
saccharide sequence and the biological functions of HS. The res-
ults suggest that a series of 3-OST isoforms synthesize the unique
gD-binding 3-O-sulphated HS, demonstrating the important and
complex roles of HS in promoting HSV-1 infection.
MATERIALS AND METHODS
Materials
Na235SO4 was purchased from ICN. Human AT (antithrombin)
was from Cutter Biological (Berkeley, CA, U.S.A.). A truncated
form of HSV-1 gD, gD-1 (306t), and monoclonal anti-gD (DL6)
were gifts from Dr Cohen and Dr Eisenberg of the University
of Pennsylvania (Philadelphia, PA, U.S.A.). The preparations of
plasmid expressing human 3-OST-5 (pcDNA3.1-3OST5) and
human 3-OST-5 stable expression CHO (3OST5/CHO) cells have
been described elsewhere [9,27].
Cell culture and viruses
CHO cells were maintained in exponential growth by subculturing
twice a week at 37 ◦C under 6% CO2 humidified atmosphere.
CHO cells were grown in Ham’s F-12 medium (Invitrogen) sup-
plemented with 10% (v/v) foetal bovine serum (JRH Bio-
sciences, Lenexa, KS, U.S.A.). 3OST5/CHO cells were main-
tained in Ham’s F-12 medium supplemented with 10% (v/v)
foetal bovine serum and 1 mg/ml Geneticin (G418 sulphate, In-
vitrogen). Recombinant β-galactosidase-expressing viruses,
HSV-1(KOS)gL86, HSV-1(KOS)tk12, HSV-2(333)gJ-, gH-nega-
tive PRV(Kaplan) (pseudorabies virus) and BHV-1(Cooper)
(bovine herpesvirus), were cultured as described elsewhere [28].
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Isolation of 3-OST-6 cDNA
Screening the GenBank® database with human 3-OST-3 amino
acid sequence, an exon coding for the catalytic domain of 3-OST-6
was identified from a human genomic clone with the accession no.
AE006640.1. After further probing the EST (expressed sequence
tag) database with the deduced partial amino acid sequence of
human 3-OST-6, its mouse homologue (with 94% identity
with 3-OST-6 amino acid sequence) was found (accession
no. AI447860). The insert of this EST clone was fully sequenced
for both strands, revealing a complete ORF (open reading
frame). The insert was then cloned into a pcDNA3 vector using
EcoRI/XbaI sites (pcDNA3-3OST6).
Expression of 3-OST-6
Preparation of Myc-tagged 3-OST-6 expression vector
We introduced Myc and His6 tags at the C-terminal of 3-OST-6
by subcloning 3-OST-6 cDNA into pcDNA3.1/Myc-His vector
(Invitrogen). The ORF of 3-OST-6 was amplified from pcDNA3-
3OST6 by PCR using the 5′-specific primer, 5′-GAGCTCG-
GATCCACTAGTAACGGC-3′; and the 3′-specific primer, 5′-AA-
ATTTCTCGAGGACCCAGCCAAAGTCCTG-3′ (XhoI site un-
derlined). The PCR product was subcloned into pcDNA3.1/Myc-
His using EcoRI/XhoI sites. The coding region was completely
sequenced for both strands (pcDNA3.1-3OST6-Myc-His).
Preparation of 3-OST-6 stable expression cells (3OST6/CHO)
The expression plasmid pcDNA3.1-3OST6-Myc-His was trans-
fected into wild-type CHO cells using LIPOFECTAMINE 2000
(Invitrogen) following the manufacturer’s protocol. At 6 days
after transfection, the cells were trypsinized and transferred into
a 48-well plate at a concentration of 0.5 cells per well. The cells
were grown in Ham’s F-12 medium containing 10% (v/v) foetal
bovine serum and 1 mg/ml Geneticin at 37 ◦C under 6% CO2
for 2–3 weeks until confluence was attained. The clone with the
highest expression level of 3-OST-6 was identified by Western
blot analysis.
Characterization of 3-OST-6 activity
In vitro assay for 3-OST-6 activity
Approx. 3 × 106 3OST6/CHO cells were mixed with 100 µl of
cold 0.25 M sucrose containing 1 % (v/v) Triton X-100. The
insoluble residues were removed after centrifuging at 10000 g
for 10 min. The HS sulphotransferase activity was determined
by incubating the cell extract with 1 µg of unlabelled HS (from
bovine kidney), 4 × 107 c.p.m. of [35S]PAPS in 50 µl of a buffer
containing 50 mM Mes, 10 mM MnCl2, 5 mM MgCl2 and 1%
(v/v) Triton X-100 (pH 7). The reaction was incubated at 37 ◦C
for 1 h and was then subjected to a 200 µl DEAE-Sepharose
column to purify [35S]HS. The resultant [35S]HS was subjected to
the disaccharide analysis as described below.
Metabolically labelling 3OST6/CHO cells and the preparation of [35S]HS
CHO-K1 and 3OST6/CHO cells were grown to 60–70 % conflu-
ence in T-75 flasks. Cells were then incubated with 5 ml of growth
medium containing 1 mCi/ml of Na235SO4 for 10 h at 37 ◦C. The
[35S]HS was purified using DEAE chromatography.
Disaccharide analysis of [35S]HS
The [35S]HS isolated from 3OST6/CHO cells was degraded
with nitrous acid at pH 1.5, followed by reduction with sodium
borohydride [29]. The disaccharides were resolved by a C18
reverse-phase column (0.46 cm × 25 cm) (Vydac) under the
RPIP-HPLC (reverse-phase ion-pairing HPLC) condition [30].
The identities of the disaccharides were determined by co-eluting
with appropriate 3H-labelled and 35S-labelled disaccharides [30].
Western blot analysis
Approx. 300 µg of cell extract was resolved on SDS/13%
PAGE and was transferred on to a nitrocellulose membrane
(Amersham Biosciences). Biotinylated protein molecular-mass
markers (1 µg) (Amersham Biosciences) were used as the mole-
cular-mass standards, and the markers were probed by avidin–
horseradish peroxidase (Amersham Biosciences). Myc-tagged
3-OST-6 protein was detected by using mouse anti-Myc antibody
(Invitrogen) followed by horseradish-peroxidase-conjugated
anti-mouse IgG secondary antibody (Amersham Biosciences).
ECL® (enhanced chemiluminescence) Western blotting detection
reagents (Amersham Biosciences) were used to induce chemilu-
minescence, and the blot was exposed to X-ray film (Kodak) for
15 min.
Determination of the bindings of 3-O-sulphated HS to AT
and HSV gD-1
Determination of the binding of HS to AT
The AT binding of HS isolated from 3OST6/CHO cells was per-
formed by using an AT/Con A (concanavalin A)–Sepharose
approach [13]. Briefly, [35S]HS (100000 c.p.m.) was incubated
in 150 µl of a buffer containing 10 mM Tris/HCl, 150 mM
NaCl, 1 µM dextran sulphate, 1 mM Ca2+, Mg2+ and Mn2+, and
0.1 mg/ml AT (pH 7.5), at room temperature (25 ◦C) for 30 min.
The solution was mixed with the prewashed Con A–Sepharose
(60 µl of 1:1 slurry) and agitated at room temperature for 1 h. The
gel was then washed three times with 1 ml of a buffer containing
10 mM Tris/HCl, 0.0004% (v/v) Triton X-100 and 150 mM NaCl
(pH 7.5). The HS was eluted from the gel using 1 ml of a buffer
containing 10 mM Tris/HCl, 1000 mM NaCl and 0.0004% (v/v)
Triton X-100 (pH 7.5).
Determination of the binding of gD to HS
The assay for determining the binding of 3-O-sulphated HS
to gD was carried out by an immunoprecipitation procedure
using anti-gD monoclonal antibody [14]. The [35S]HS (100000–
200000c.p.m.) was incubated in 50 µl of a buffer containing
50 mM Tris/HCl, 150 mM NaCl and 0.01 % (v/v) Triton (pH 7)
(binding buffer), and 2 mg/ml of gD at room temperature for
30 min. The anti-gD monoclonal antibody DL6 (5 µl) was added
and incubated at 4 ◦C for 1 h followed by the addition of Protein
A–agarose gel (80 µl of 1:1 slurry) and agitated at 4 ◦C for an
additional 1 h. The gD-binding HS was eluted from the gel with
1 ml of 1 M NaCl in the binding buffer.
HSV entry assay
Viral entry assays were based on the quantification of the
activity of β-galactosidase from the recombinant HSV viruses
in which the expression of β-galactosidase is turned on upon
viral entry into mammalian cells [14,22,23]. Briefly, wild-type
CHO-K1, 3OST5/CHO and 3OST6/CHO cells were plated (2–
4 × 104 cells/well) in 96-well culture dishes for 14 h before the
infection by recombinant HSV-1 (KOS). In separate experiments,
other members of the alphaherpesvirus subfamily expressing
β-galactosidase, including HSV-2(333), PRV (gH−) and BHV-1,
were tested for their entry into 3OST6/CHO cells. Wild-type CHO
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Figure 2 Nucleotide and deduced amino acid sequences of mouse 3-OST-6
The single predicted membrane-spanning domain and a potential N-linked glycosylation site are indicated by the double underlining and by the underlining with a  below the glycosylated
asparagine residue respectively.
cells and the CHO cells expressing nectin-1 were used as positive
and negative controls respectively throughout the study [23]. Cells
(post-infection) were assayed for the activity of β-galactosidase
[15].
Cell–cell fusion assay
The assay was described in a report by Pertel et al. [31]. Briefly,
subconfluent wild-type CHO-K1 ‘effector cells’ in a six-well dish
were transfected with plasmids expressing HSV-1 glycoproteins:
gB (pPE98), gD (pEP99), gH (pEP100) and gL (pEP101) and T7
RNA polymerase (0.5 µg/well of each plasmid). In a separate six-
well dish, CHO K-1 ‘target cells’ were transfected with 3-OST-5
or 3-OST-6 plasmids (1.0 µg/well) and vectors expressing luci-
ferase under the control of the T7 promoter. The total amount of
DNA transfected was kept constant at 2.5 µg/well by balancing
with the vector plasmid (pcDNA3.1). LIPOFECTAMINE reagent
(Invitrogen) in Opti-MEM (Gibco) was used for all transfections.
After incubation at 37 ◦C in 5% CO2 for 16 h, the mixture was
removed. Ham’s F-12 containing 10% (v/v) foetal bovine serum
was added, and the cells were incubated for an additional 4 h. Cells
were detached subsequently using trypsin-EDTA. The effector
and target cells were mixed at a 1:1 ratio before plating on
to 24-well plates. The luciferase activity was quantified using
the Luciferase Reporter Assay System (Promega, Madison, WI,
U.S.A.), and the cell–cell fusion microimages were captured
24 h after the mixing. Cell fusion was visualized by microscopy
following Giemsa staining. Microscopy was performed using
×20 objective of the inverted microscope (Zeiss, Axiovert 100M).
The Slidebook version 3.0 (Intelligent Imaging Innovations,
Cambridge, MA, U.S.A.) was used for recording the images.
Northern blot analysis
The coding sequence of 3-OST-6 was used as a template to pre-
pare the 32P-labelled probe using the Random Primer Kit
(Stratagene) and [α-32P]dCTP to hybridize the Mouse MTN
(Multiple Tissue Northern) blot (Clontech). The hybridization
was carried out in a standard hybridization buffer [5 × SSC
(1 × SSC is 0.15 M NaCl/0.015 M sodium citrate, pH 7.0),
5 × Denhardt’s solution (1 × Denhardt’s solution is 0.2 mg/ml
Ficoll 400/0.2 mg/ml polyvinylpyrrolidone/0.2 mg/ml BSA) and
0.5% SDS] at 68 ◦C overnight, and the blot was washed twice with
2 × SSC containing 0.05% (w/v) SDS at room temperature for
30 min), followed by washing twice with 0.1 × SSC containing
0.1% (w/v) SDS at 50 ◦C for 40 min. The membrane was exposed
to X-ray film (Kodak) for 5 days.
RESULTS
Isolation of the cDNA encoding 3-OST-6
Screening the non-redundant database of GenBank® with the de-
duced amino acid sequence of human 3-OST-3 (accession no.
NM 006042), we identified an exon coding for the catalytic do-
main of a novel 3-OST. Probing the EST database further with the
deduced partial sequence of the novel human sulphotransferase,
a mouse homologue (with 94% identity in amino acid sequence)
was identified from an EST cDNA clone with accession
no. AI447860. This protein contains a complete ORF encoding
a protein with 342 amino acid residues, and was designated
3-OST-6 (Figure 2). It has a single potential N-glycosylation site
with the predicted molecular mass of 37417 Da. The deduced
amino acid sequence has 87, 63 and 61% identity with m3-OST-3
and m3-OST-5 and m3-OST-1 in the sulphotransferase domain
respectively. The amino acid sequence alignment of 3-OST-1,
-3A, -5 and -6 is shown in Figure 3. Putative PAPS-binding sites
were also found in 3-OST-6, based upon the consensus sequences
(Figure 3) [10,32].
Determination of the sulphotransferase activity of 3-OST-6
Because 3-OST-6 has high identity with 3-OST-1, 3-OST-3 and
3-OST-5, we decided to examine its ability to generate
c© 2005 Biochemical Society
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Figure 3 Multiple amino acid sequence alignment of mouse 3-OST-6 with mouse 3-OST-1, 3-OST-3A and 3-OST-5
The alignment was performed by using the BioEdit program. Introduced gaps are shown as dashes, and aligned amino acids are boxed and shaded black for identical residues and dark grey for
similar residues. 5′-PBS represents the putative domain that binds to the 5′-phosphate of PAPS, and 3′-PBS represents the putative domain that binds to the 3′-phosphate of PAPS.
Figure 4 Western blotting analysis of 3OST6/CHO cell extract
3OST6/CHO and CHO-K1 cell extracts were resolved on SDS/13 % PAGE. Myc-tagged 3-OST-6
was detected by incubating the blot with mouse anti-Myc antibody and then horseradish-
peroxidase-conjugated anti-mouse IgG secondary antibody. The apparent molecular masses of
the two bands were approx. 38 kDa and 41 kDa. The predicted molecular mass of 3-OST-6–
Myc/His is 37.4 kDa. Molecular masses of standards are given to the right of the gel.
3-O-sulphated HS in transfected cells. Initially, we transiently
expressed 3-OST-6 (pcDNA3-3OST-6) in COS-7 cells, however,
we failed to detect any 3-OST activity in the transfected cells using
an in vitro assay (results not shown). To overcome this problem,
a CHO cell line with stable expression of 3-OST-6 (3OST6/CHO
cells) was prepared, where a Myc-tag was introduced to the
C-terminus of the protein for monitoring the level of expression
of 3-OST-6.
Western blot analysis using anti-Myc antibody was performed
on the lysates obtained from 3OST6/CHO cells and non-
transfected CHO cells (CHO-K1 cells, as a negative control)
(Figure 4). We observed two protein bands in the lysate of CHO/
3OST6 cells at the molecular masses of 38 and 41 kDa (Figure 4),
whereas no signals were detected in the non-transfected CHO
cells. The protein band with lower molecular mass was very close
to the predicted molecular mass (37.4 kDa) of 3-OST-6. The
protein band with higher molecular mass probably represented
the 3-OST-6 with glycosylation or other post-translational modi-
fications.
To characterize substrate specificity of 3-OST-6, we analysed
the structure of the HS isolated from 3OST6/CHO cells by con-
ducting the disaccharide analysis. The 3OST6/CHO cells were
metabolically labelled with Na235SO4, and the [35S]HS was iso-
lated. The resultant [35S]HS was subjected to nitrous acid degrad-
ation at pH 1.5, followed by sodium borohydride reduction to
prepare 35S-labelled disaccharides (the schematic representation
of the disaccharide analysis of [35S]HS illustrated in Figure 5C).
The 35S-labelled disaccharides were resolved by RPIP-HPLC,
and the chromatograms are shown in Figure 5. Comparing the
profiles of the degraded [35S]HS that was isolated from CHO-K1
cells (Figure 5A), we found two additional 35S-labelled di-
saccharides in the HS from 3OST6/CHO cells (Figure 5B). Those
two 35S-labelled disaccharides were 3-O-sulphated disaccharides
with the structures of IdoA2S-AnMan3S (eluted at 36.5 min)
and IdoA2S-AnMan3S6S (eluted at 69.5 min) by co-eluting with
the disaccharide standards [30]. A large peak of 35S-labelled di-
saccharide with a structure of IdoA2S-AnMan6S (AnMan6S is
2,5-anhydromannitol 6-O-sulphate) was also observed (eluted
at 56–58 min) both in the samples from CHO-K1 and 3OST6/
CHO. The presence of 35S-labelled IdoA2S-AnMan6S is expected
because it is a common disaccharide in HS. We should also
observe IdoA-AnMan6S after nitrous acid (pH 1.5) degradation
of [35S]HS, which is a monosulphated disaccharide from nitrous
acid degraded polysaccharide. To identify this monosulphated
disaccharide requires a different HPLC condition. The HPLC
condition used in the present study is designed to identify both
disulphated and trisulphated disaccharides [30]. This condition
provides the best resolution among disulphated and trisulphated
disaccharides. However, it does not provide the best resolution
for monosulphated disaccharides. These results suggest that the
HS isolated from 3OST6/CHO cells contain 3-O-sulphated HS,
therefore 3-OST-6 encodes a protein with the anticipated 3-OST
activity. Unlike previously reported 3-OST isoforms, we were
unable to detect the 3-OST activity in the lysate of 3OST6/CHO
cells by an in vitro assay, suggesting a unique biochemical
property of 3-OST-6. In a parallel control experiment, we readily
observed the activity of 3-OST-5 in the extract of 3OST5/CHO
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Figure 5 RPIP-HPLC chromatograms of the disaccharide analysis of HS
isolated from 3OST6/CHO cells
[35S]HS was extracted from CHO-K1 (A) and 3OST6/CHO (B) cells after incubating them
with Na235SO4. [35S]HS was then depolymerized by nitrous acid at pH 1.5, followed by
sodium borohydride reduction. The resultant 35S-labelled disaccharides were resolved on
RPIP-HPLC. The elution positions of disaccharides are indicated by arrows, where arrow 1
represents IdoA2S-AnMan3S, arrow 2 represents IdoA2S-AnMan6S, and arrow 3 represents
IdoA2S-AnMan3S6S. (C) The reaction used for degrading HS with nitrous acid. Nitrous acid (at
pH 1.5) reacts with an N-sulphated glucosamine (GlcNSO3) unit to form 2,5-anhydromannitol
(AnMan). The identities of the resultant disaccharides were determined by co-eluting with
disaccharide standards on RPIP-HPLC.
cells by using this in vitro assay (results not shown). It is important
to note that IdoA2S-AnMan3S and IdoA2S-AnMan3S6S are
characteristic gD-binding HS disaccharides [14] (structures
shown Figure 1).
The activity of 3-OST-6 in assisting HSV-1 entry and cell–cell fusion
Non-transfected CHO cells are resistant to HSV-1 infection.
However, introduction of the cDNA that allows the cells to
synthesize an entry receptor renders the susceptibility of CHO
cells to HSV-1 infection. A significant increase in β-galactosidase
activity was observed in 3OST6/CHO cells infected by HSV-1,
compared with that of CHO-K1 cells (Figure 6A). Furthermore,
the level of β-galactosidase was comparable with the HSV-
1-infected cells that stably express 3-OST-5 (3OST5/CHO)
(Figure 6A). 3-OST-5 is known to generate an entry receptor
for HSV-1 [9]. We also compared the activity of β-galactosidase
Figure 6 Entry of HSV-1 into 3OST6/CHO cells and CHO-K1 cells
(A) As indicated, 3OST6/CHO, 3OST5/CHO and CHO-K1 cells were infected with several PFUs
(plaque-forming units)/well of HSV-1(KOS-gL86). The cells were lysed for the quantification of
β-galactosidase activity as a measure of viral entry. Attenuance at 410 nm (OD 410 nm)
of ONPG (o-nitrophenyl β-D-galactopyranoside) reaction products were plotted against PFUs
used. 3OST6/CHO (B) and CHO-K1 (C) cells were exposed to KOS-gL86 at 100 (PFUs)/cell.
At 6 h later, the cells were washed, fixed and incubated with X-gal (5-bromo-4-chloroindol-3-yl
β-D-galactopyranoside) to identify infected cells (dark cells).
Table 1 Binding of 3OST6/CHO HS to gD and AT
Binding of the HS and gD was determined by incubating modified [35S]HS with gD followed by
immunoprecipitation using anti-gD monoclonal antibody (DL6) to precipitate the complex of
[35S]HS and gD. Results are means +− S.D. Binding of HS to AT was determined by incubating
modified [35S]HS and AT by using an AT/ConA–Sepharose gel as described in the Materials
and methods section. The control was the [35S]HS extracted from CHO-K1 cells labelled with
Na235SO4.
Binding to gD (%) Binding to AT (%)
Control 3.8 +− 0.9 (n = 2) 0.5 +− 0.1 (n = 3)
HS from 3OST6/CHO 8.8 +− 2.0 (n = 2) 0.8 +− 0.2 (n = 3)
HS from 3OST5/CHO 7.3 (n = 1) 4.1 +− 1.2 (n = 3)
in situ. As expected, nearly all of 3OST6/CHO cells were
susceptible (Figure 6B, dark cells) to the entry of HSV-1. Clearly,
no dark cells were observed in CHO-K1 cells infected with
the same HSV-1 (Figure 6C). Our results suggest that 3-OST-6
renders the susceptibility of CHO cells to HSV-1 infection. A
direct binding between 3-OST-6-modified HS to gD was also
detected (Table 1). As expected, the HS from 3OST6/CHO cells
has an approx. 2.3-fold increase in binding to gD as compared with
the HS from CHO-K1; a similar increase was observed for the
HS from 3OST5/CHO cells. Taken together, these observations
are consistent with the conclusion that 3-OST-6 generates HSV-1
entry receptor and that the entry mediating activity of 3-OST-6 is
very similar to that of 3-OST-5.
In separate experiments, we also examined the activity of 3-
OST-6 in assisting the entry of other members of alphaherpesvirus
c© 2005 Biochemical Society
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Figure 7 Cell–cell fusion mediated by 3-O-sulphated HS
(A) Cell fusion is dependent on expression of 3-OST-6. CHO-K1 cells were used as effector and
target cell. Effector cells were transfected with plasmid expressing HSV-1 glycoproteins and luci-
ferase reporter plasmids. Target cells were transfected with T7 RNA polymerase and the
plasmid expressing 3-OST-5 or 3-OST-6. Luciferase activity was measured 24 h after mixing
and co-cultivating the effector and target cells. The luciferase activity is from one experiment
performed in triplicate. (B) and (C) are the microscopic images for the observation of HSV-1 gly-
coprotein-induced cell fusion. CHO-K1 effector cells were transfected with HSV-1 glycoproteins
(gB, gD, gH and gL). The target CHO-K1cells were transfected either with an empty vector
(B) or with the plasmid expressing 3-OST-6 (C). Cells were fixed and then stained with
Giemsa. Shown are the photographs of representative cell monolayers taken after 24 h. Arrows
(in C) indicate the polykaryocyte cells.
subfamily, including HSV-2, PRV and BHV-1. We found that,
very much in line with previously characterized 3-O-sulphated HS
generated by 3-OST-3 and 3-OST-5 [9,14], the cells expressing
3-OST-6 are resistant to the infection by these other members of
the alphaherpesvirus subfamily (results not shown).
To strengthen further the conclusion that 3-OST-6-modified
HS provides an entry receptor for HSV-1, we examined whether
3-OST-6-expressing cells (target cells) could induce fusion with
the cells that express HSV-1 envelope proteins essential for
viral fusion (effector cells). This cell–cell fusion assay mimics
the fusion of HSV-1 to the target cells, and the fused cells are
readily quantified with an appropriate reporter gene and visualized
under a microscope. In the assay, the target cells also carried
an inducible luciferase as a reporter gene that is activated upon
the fusion with effector cells to permit quantification of the
cell–cell fusion [15,31]. As shown in Figure 7(A), we found
that CHO cells transiently transfected with 3-OST-6 efficiently
fused with the effector cells expressing gB, gD, gH and gL,
as determined by the elevated level of luciferase. The fusion
between cells was very similar to that observed with similarly
transfected 3-OST-5 cells, which served as a positive control for
the fusion experiment [34]. The cell–cell fusion mediated by 3-
OST-6 was also visualized. Cells expressing 3-OST-6 resulted
in polykaryocyte formation, an indication of cell–cell fusion
(Figure 7C), whereas no polykaryocytes were observed using
CHO-K1 as target cells (Figure 7B). These data also suggest that
3-O-sulphated HS can potentially mediate viral spread among
neighbouring cells.
Figure 8 Expression of 3-OST-6 mRNA in mouse tissues
A mouse MTN blot was hybridized with mouse 3-OST-6 cDNA probes labelled with [32P]dCTP
under the conditions described in the Materials and methods section. Sizes (in kb) are indicated
to the left of the blot.
3-OST-6 does not generate AT-binding HS
The binding of the HS from 3OST6/CHO to AT was also
determined to evaluate the substrate specificity of 3-OST-6, as
the saccharide sequences for binding to gD (serving as HSV-1
entry receptor) and AT (having anticoagulant property) are
distinct. The results from this experiment allowed us to identify
whether 3-OST-6 is more similar to 3-OST-3 or to 3-OST-5 (as
shown in Figure 1). We observed only 0.8 % of 3OST6/CHO
HS bound to AT, which is very close to that of the HS isolated
from non-transfected CHO cells (0.5%) (Table 1). In contrast, the
binding of 3OST5/CHO HS to AT was 7.6-fold higher than
the that of the HS from non-transfected CHO cells control sample,
which is consistent with the conclusion that 3-OST-5 generates
AT-binding sites [9]. The results from AT-binding assay suggest
that 3-OST-6 does not generate AT-binding sites. Therefore the
substrate specificity of 3-OST-6 and 3-OST-5 is distinct.
Tissue distribution of 3-OST-6
Northern blot analysis was carried out on a mouse MTN blot using
3-OST-6 probe. We detected that 3-OST-6 is expressed primarily
in liver with sizes of ∼1.6 kb and ∼3.6 kb, and in kidney with
a size of ∼1.6 kb, and is also expressed at lower levels in heart,
brain, lung and testis (Figure 8).
DISCUSSION
HSV-1 utilizes distinct families of cell-surface molecules as
entry receptors for infection via an unknown mechanism [18].
One of the families is 3-O-sulphated HS, which interacts
with gD with a binding affinity in the micromolar range [6].
The 3-O-sulphated HS is biosynthesized by specific 3-OSTs.
In the present study, we report the isolation and characterization
of a novel 3-OST cDNA, namely 3-OST-6. To our knowledge,
the biochemical functions and enzymic activity of this gene
have not been reported. The cDNA was identified by homology
c© 2005 Biochemical Society
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search using the amino acid sequence of 3-OST-3, a known
sulphotransferase that synthesizes an entry receptor for HSV-1
[14]. We utilized a similar approach to successfully identify
3-OST-5 [9]. Our results demonstrated that 3-OST-6 cDNA
encodes a protein that has 3-OST activity, and synthesizes an entry
and cell–cell fusion receptor for HSV-1, but not for other subtypes
of the alphaherpesvirus family. The isolated cDNA encodes a
type II membrane-bound protein, which is consistent with the
structural features found in all previously characterized 3-OST
isoforms, including 3-OST-1 [a secreted enzyme, containing a
signal peptide (12-amino-acids long)], 3-OST-2, 3-OST-3 and
3-OST-5[8,9].Thefull-lengthcDNAsequencefor3-OST-4hasnot
been published. As expected, the HS isolated from 3OST6/CHO
cells binds to gD and contains two characteristic 3-O-sulphated
disaccharides (IdoA2S-AnMan3S and IdoA2S-AnMan3S6S),
suggesting that 3-OST-6 sulphates similar disaccharides to those
sulphated by 3-OST-3 (for substrate specificity of 3-OST-3, see
Figure 1). It should be noted, however, that we do not know
whether the saccharide sequences of the gD-binding sites in
3-OST-3-modified HS and those in 3-OST-6-modified HS are
identical. We also identified the human 3-OST-6 from a genomic
clone with accession number AE006640.1, because the gene
encodes a protein having 94 % sequence identity with mouse
3-OST-6.
One of the reasons for successfully characterizing the sulpho-
transferase activity of 3-OST-6 was that we obtained a CHO cell
clone that stably expresses 3-OST-6 gene. It is very interesting
to note that we were unable to detect the activity of 3-OST-6
in the cellular extract using an in vitro assay, which has been
successfully used to characterize all previously reported 3-OSTs
[9,12,33]. This observation suggests two possible explanations:
either 3-OST-6 activity is unstable under in vitro experimental
conditions, or the enzyme sulphates a very unique HS substrate
that is absent in the HS utilized for the in vitro assay. (HSs
from three different sources, including the HS from bovine
kidney, from non-transfected CHO cells and from mouse L-cells,
were examined. None of these HSs is a substrate of 3-OST-6.)
The physiological functions of 3-O-sulphated HS, generated by
3-OST-3, 3-OST-2 and 3-OST-6, are not known despite the fact
that it serves as an entry receptor for HSV-1. It is known that
the 3-O-sulphated HS biosynthesized by 3-OST-1 serves as an
anticoagulant on the surface of endothelial cells, although 3-OST-
1-modified HS is not an entry receptor for HSV-1 [14,27,38].
The 3-O-sulphated HS biosynthesized by 3-OST-5 display the
activities in anticoagulation and in assisting HSV-1 entry [9].
Reports suggest that 3-O-sulphated HS could be involved in
numerous biological functions, and 3-OST genes are present
among the animal kingdoms from Caenorhabditis elegans and
Drosophila to humans [10,34]. Edge and Spiro [35] reported that
decreased levels of IdoA-AnMan3S and IdoA2S-AnMan3S in HS
isolated from the glomerular basement membrane were observed
in diabetic patients. Since IdoA2S-AnMan3S is the product of
3-OST-3, 3-OST-2, 3-OST-6 or 3-OST-5, and IdoA-AnMan3S is
the product of 3-OST-5, these results suggest that the specific 3-O-
sulphated HS might contribute to defects in the anionic filtration
barrier in diabetic patients. The expression of 3-OST-2 in rat pineal
gland is daylight-sensitive and is regulated by the β-adrenergic
signalling pathway [36]. In addition, a lower expression of
3-OST-2 was discovered in various human cancers, suggesting
potential roles of 3-OST-2 in controlling the transformation of
normal cells to cancer cells [37].
The wide host range of HSV infection is possibly because of the
ability of the virus to use multiple cell-surface molecules, includ-
ing 3-O-sulphated HS, for entry [21]. The discovery of 3-OST-6 as
an enzyme for the biosynthesis of a gD receptor adds to the
Table 2 Tissue distributions of 3-OST isoforms and the biological functions
of 3-O-sulphated HS
Tissue distributions of human 3-OST-1, -2, -3A, -3B and -4 were reported by Shworak et al.
[10]. Tissue distribution of human 3-OST-5 was reported by Xia et al. [9] and Mochizuki et al. [11].
3-OST-3A and 3-OST-3B have nearly identical amino acid sequences in the sulphotransferase
domain, and sulphate the same disaccharides as described in Figure 1 [10,12]. 3-OST-4
sulphates the same disaccharides as 3-OST-3A [39]. 3-OST-2 sulphates the GlcN residue that
links to an IdoA2S residue as well as the GlcN residue that links to a GlcA2S residue [12]. For
clarity, the complete substrate specificity of 3-OST-2 is not shown in Figure 1. The activities of
3-OST-2 and 3-OST-4 in assisting the entry of HSV-1 were reported by Shukla and Spear [6].
3-OSTs isoform Tissue distribution Known properties
3-OST-1 Heart, brain, lung, kidney Anticoagulant HS
3-OST-2 Brain HSV-1 entry
3-OST-3A Heart, placenta, lung, liver, kidney HSV-1 entry
3-OST-3B Heart, brain, lung, liver, kidney HSV-1 entry
3-OST-4 Brain HSV-1 entry
3-OST-5 Brain, spinal cord, skeletal muscle Anticoagulant HS and HSV-1 entry
3-OST-6 Liver, kidney HSV-1 entry
growing body of evidence that several members of 3-OST family
generate such receptors. Collectively, these members are ex-
pressed in a wide variety of human cell types and tissues (Table 2).
Thus wide expression of the enzymes raises the possibility that
3-O-sulphated HS is present in many cell types, and could poten-
tially play a significant role in HSV-1 entry and spreading
during primary or disseminated diseases. The disseminated form
usually involves the liver, adrenal gland and lung. It is very
interesting that 3-OST-6, along with 3-OST-3, is expressed in the
liver. We reported recently that co-expression of 3-OST isoforms
can actually enhance HSV-1 entry and cell fusion, potentially by
enhancing the gD-binding sites within HS chains [15]. It raises the
possibility that co-expression of 3-OST-6 and 3-OST-3 could also
enhance the susceptibility of liver cells for HSV-1. This possibility
would require further experiments to confirm.
Similarly, the inability of 3-O-sulphated HS to mediate HSV-2
entry raises the possibility of mechanistic differences between
the entry of HSV-1 and -2, where HSV-2 infections commonly
occur in genital tissues. The differences could be at the level of
receptor recognition or at a subsequent step during the entry. In
either case, our observation suggests that receptors could play a
role in deciding the tissue tropism. More conclusive studies on
the cellular expression of 3-OSTs and their significance in cell
types that are natural hosts to HSV-1 are needed to test this possi-
bility. Such studies will be beneficial not only for understanding
the pathogenic effects of the virus, but also to dissect it from
HSV-2 pathogenesis.
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